Search research articles
Contact Us
Filters
Showing results (1031-1040 of 1,154) with videos related to
Page
of 116
Sort By:
Faraday Discussions
|
June 6, 2017
VOC emission rates over London and South East England obtained by airborne eddy covariance
Adam R Vaughan, James D Lee, Marvin D Shaw, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 25, 2021
Longitudinal Investigation of Pubertal Milestones and Hormones as a Function of Body Fat in Girls
Madison T Ortega, John A McGrath, Lauren Carlson, et al.
Annals of Surgery
|
June 24, 1998
Reduction of hepatic ischemia/reperfusion injury by a soluble P-selectin glycoprotein ligand-1
T S Dulkanchainun, J A Goss, D K Imagawa, et al.
Nature Communications
|
October 15, 2017
Entanglement between more than two hundred macroscopic atomic ensembles in a solid
P Zarkeshian, C Deshmukh, N Sinclair, et al.
Circulation
|
January 15, 1996
Coronary thrombi increase PTCA risk. Angioscopy as a clinical tool
C J White, S R Ramee, T J Collins, et al.
Molecular Microbiology
|
December 30, 2015
In vitro selection of miltefosine resistance in promastigotes of Leishmania donovani from Nepal: genomic and metabolomic characterization
C D Shaw, J Lonchamp, T Downing, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik
|
August 29, 2018
Resistance to Rhynchosporium commune in a collection of European spring barley germplasm
Mark E Looseley, Lucie L Griffe, Bianca Büttner, et al.
Journal of Medicinal Chemistry
|
January 5, 2007
2-(4-Chlorobenzyl)-3-hydroxy-7,8,9,10-tetrahydrobenzo[H]quinoline-4-carboxylic acid (PSI-697): identification of a clinical candidate from the quinoline salicylic acid series of P-selectin antagonists
Neelu Kaila, Kristin Janz, Adrian Huang, et al.
Faraday Discussions
|
April 22, 2016
Spatially resolved flux measurements of NOx from London suggest significantly higher emissions than predicted by inventories
Adam R Vaughan, James D Lee, Pawel K Misztal, et al.
Trials
|
May 30, 2025
A phase 3 study of ravulizumab to protect patients with chronic kidney disease from cardiac surgery-associated acute kidney injury and major adverse kidney events (ARTEMIS)
Marlies Ostermann, David C Corteville, Kent Doi, et al.
Page
of 116
Search research articles
Search
Showing results (1031-1040 of 1,154) with videos related to
Sort By:
Page
of 116
Faraday Discussions
|
June 6, 2017
VOC emission rates over London and South East England obtained by airborne eddy covariance
Adam R Vaughan, James D Lee, Marvin D Shaw, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 25, 2021
Longitudinal Investigation of Pubertal Milestones and Hormones as a Function of Body Fat in Girls
Madison T Ortega, John A McGrath, Lauren Carlson, et al.
Annals of Surgery
|
June 24, 1998
Reduction of hepatic ischemia/reperfusion injury by a soluble P-selectin glycoprotein ligand-1
T S Dulkanchainun, J A Goss, D K Imagawa, et al.
Nature Communications
|
October 15, 2017
Entanglement between more than two hundred macroscopic atomic ensembles in a solid
P Zarkeshian, C Deshmukh, N Sinclair, et al.
Circulation
|
January 15, 1996
Coronary thrombi increase PTCA risk. Angioscopy as a clinical tool
C J White, S R Ramee, T J Collins, et al.
Molecular Microbiology
|
December 30, 2015
In vitro selection of miltefosine resistance in promastigotes of Leishmania donovani from Nepal: genomic and metabolomic characterization
C D Shaw, J Lonchamp, T Downing, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik
|
August 29, 2018
Resistance to Rhynchosporium commune in a collection of European spring barley germplasm
Mark E Looseley, Lucie L Griffe, Bianca Büttner, et al.
Journal of Medicinal Chemistry
|
January 5, 2007
2-(4-Chlorobenzyl)-3-hydroxy-7,8,9,10-tetrahydrobenzo[H]quinoline-4-carboxylic acid (PSI-697): identification of a clinical candidate from the quinoline salicylic acid series of P-selectin antagonists
Neelu Kaila, Kristin Janz, Adrian Huang, et al.
Faraday Discussions
|
April 22, 2016
Spatially resolved flux measurements of NOx from London suggest significantly higher emissions than predicted by inventories
Adam R Vaughan, James D Lee, Pawel K Misztal, et al.
Trials
|
May 30, 2025
A phase 3 study of ravulizumab to protect patients with chronic kidney disease from cardiac surgery-associated acute kidney injury and major adverse kidney events (ARTEMIS)
Marlies Ostermann, David C Corteville, Kent Doi, et al.
Page
of 116